Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,470,820
+$4,382,554 QoQ
Shares Held
310,250
+182.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#490
of 2,834 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Larson Financial Group LLC holds $64,664,035 across 17 Drug Manufacturers - General names. PFE ranks #4 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,831 | $26,184,758 | |
| 2 | ABBV |
AbbVie Inc.
|
35,918 | $9,038,405 | |
| 3 | MRK |
Merck & Co., Inc.
|
63,932 | $8,215,262 | |
| 4 | PFE |
Pfizer Inc
This page
|
310,250 | $7,470,820 | |
| 5 | JNJ |
Johnson & Johnson
|
27,845 | $7,071,794 | |
| 6 | AMGN |
Amgen Inc
|
7,025 | $2,543,893 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
25,994 | $1,497,774 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
11,716 | $1,480,199 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,470,820 | 310,250 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,088,266 | 109,981 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,374,348 | 135,516 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,348,250 | 131,407 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,041,198 | 125,462 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,637,159 | 104,071 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,564,548 | 96,666 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,584,023 | 89,289 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,662,767 | 59,427 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $937,089 | 33,769 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $652,611 | 22,668 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $674,777 | 20,343 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $612,702 | 16,704 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $782,217 | 19,172 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $963,363 | 18,801 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $645,897 | 14,760 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $822,941 | 15,696 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $611,455 | 11,811 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $892,540 | 15,115 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $526,055 | 12,231 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $470,311 | 12,010 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $455,556 | 12,574 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $443,818 | 12,057 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $347,768 | 9,476 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $351,427 | 10,747 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $324,180 | 9,932 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||